Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI Functional Imaging in CRPC Treated with Cabozantinib
NCT01599793Phase 2Completed
- Sponsor
- University of Chicago
- Start
- May 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in prostate cancer (PCa), sponsored by University of Chicago. Started May 2012; status: completed.
02
Drugs
cabozantinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01599793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599793.